Healthy subjects
Conditions
Interventions
None listed
Sponsors
Macromill, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Biologically classified as female and between 20 and 60 years of age at the time of obtaining consent to participate in the study. 2. who usually use or have used tampons, have used vaginal tablets, commercial vaginal flora collection kits, or other items that must be inserted into the vagina, have had an internal examination at a gynecologist, or have given birth (in order to collect a vaginal sample). 3. Menopausal group: Those who have been menstruating for more than 1 year since their last menstrual period. 4. Hymenopausal group: Subjects whose menstrual cycle is stable between 25 and 38 days. 5. Persons who have been fully informed of the purpose and content of the study, have the capacity to consent, understand the study fully, volunteer of their own free will, and are able to give their consent through electromagnetic informed consent by the individual.
Exclusion criteria
Exclusion criteria: 1. Currently suffering from any chronic disease and receiving treatment or medication from a physician, or planning to receive treatment or medication during the study period. 2. Have experienced a genital or sexually transmitted infection within the past 6 weeks. 3. Currently taking any medications (including over-the-counter medications) with female hormonal effects: (e.g., pills, hormone replacement therapy, Mother of Life, Equol, Bastmin, Himeros, etc.) 4. Persons who have been diagnosed with diabetes mellitus 5. Receiving antibiotics (any route of administration, including oral and vaginal tablets), immunosuppressive drugs, or chemotherapy medication, or will be receiving these medications during the study period. However, patients who have been taking these medications for a period of 4 weeks from the last dose at the time of entry into the study will be allowed to participate. 6. Patients who have undergone pubic hair removal procedures such as hair removal, plucking, shaving, or hair removal from the pubic area. However, procedures other than epilation are acceptable if there has been a gap of at least 4 weeks since the last procedure at the time of entry into the study. 7. Women who are pregnant, may become pregnant, or are planning to become pregnant, and women who are breastfeeding. Excessive smokers, regular users of alcohol (more than 60 g alcohol equivalent/day), and those with an extremely irregular diet. 9. Those who are likely to undergo a major change in their living environment (e.g., move to a new residence, transfer to a new job, or travel for an extended period of time) during the study period. 10. Who are currently participating, or have participated or will participate within the next 4 weeks, in another clinical trial 11. Other subjects who are judged by the investigator to be ineligible for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Bacterial flora analysis 2. Fungal quantification | — |
Countries
Japan
Contacts
Public ContactYuki Mori
Macromill, Inc. Life Science Division Clinical Trial Business Unit Operations 2G
Outcome results
None listed